Hamid Reza Sadeghnia

Hamid Reza Sadeghnia

Auto-generated profile, based on publicly available information

Hamid Reza Sadeghnia

Pharmacological Research Center of Medicinal Plants, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
SSSeyed H. Shahcheraghi
Seyed H. Shahcheraghi
VTVenant Tchokonte-Nana
Venant Tchokonte-Nana
MLMarzieh Lotfi
Marzieh Lotfi
MLMalihe Lotfi
Malihe Lotfi
AGAhmad Ghorbani
Ahmad Ghorbani
HSHamidReza Sadeghnia
HamidReza Sadeghnia
: Glioblastoma (GBM) is the most common and malignant astrocytic glioma, accounting for about 90% of all brain tumors with poor prognosis. Despite recent advances in understanding molecular mechanisms of oncogenesis and the improved neuroimaging technologies, surgery, and adjuvant treatments, the clinical prognosis of patients with GBM remains persistently unfavorable. The signaling pathways and the regulation of growth factors of glioblastoma cells are very abnormal. The various signaling pathways have been suggested to be involved in cellular proliferation, invasion, and glioma metastasis. The Wnt signaling pathway with its pleiotropic functions in neurogenesis and stem cell proliferation is implicated in various human cancers, including glioma. In addition, the PI3K/Akt/mTOR pathway is closely related to growth, metabolism, survival, angiogenesis, autophagy, and chemotherapy resistance of GBM. Understanding the mechanisms of GBM’s invasion, represented by invasion and migration, is an important tool in designing effective therapeutic interventions. This review will investigate two main signaling pathways in GBM: PI3K/Akt/mTOR and Wnt/beta-catenin signaling pathways.

7 January 2010 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
SMSeyed Hadi Mousavi
Seyed Hadi Mousavi
ZTZ. Tayarani-Najaran
Z. Tayarani-Najaran
MAM. Asghari
M. Asghari
HSH. R. Sadeghnia
H. R. Sadeghnia

1 April 2019 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
MKMohammad Bagher Khorrami
Mohammad Bagher Khorrami
HSHamid Reza Sadeghnia
Hamid Reza Sadeghnia
APAlireza Pasdar
Alireza Pasdar
MGMajid Ghayour-Mobarhan
Majid Ghayour-Mobarhan
BRBamdad Riahi-Zanjani
Bamdad Riahi-Zanjani
MDMajid Darroudi
Majid Darroudi
Purpose: The purpose of this study was to investigate the acute toxic potential of cerium oxide nanoparticles (CNPs) synthesized by pullulan in adult male Wistar rats. Patients and methods: Thirty male Wistar rats randomly were divided into five experimental groups of six animals each. The animals were received 50, 100, 200, and 400 mg/kg CNPs for 14 consecutive days. At the end of the experiment, the rats were euthanized and histopathological evaluation of the liver and renal tissues, as well ass, the markers of serum oxidative stress including thiobarbituric acid reactive substances, total sulfhydryl content, and antioxidant capacity (using ferric reducing/antioxidant power assay) were assessed. Hematological parameters and the activity of liver function enzymes were also measured. Results: The results of this study showed that CNPs caused no significant changes in the activity of liver enzymes, hepatic and renal histopathology and hematological parameters, while significantly improved serum redox status. Conclusion: Acute administration of pullulan-mediated CNPs is safe and possess antioxidant activity.

19 July 2013 in Renal Failure
Verified
Journal Article
Closed access
HSHamid Reza Sadeghnia
Hamid Reza Sadeghnia
BYBahareh Sadat Yousefsani
Bahareh Sadat Yousefsani
MRMoien Rashidfar
Moien Rashidfar
MBMohammad Taher Boroushaki
Mohammad Taher Boroushaki
EAElham Asadpour
Elham Asadpour
AGAhmad Ghorbani
Ahmad Ghorbani
Hexachlorobutadiene (HCBD) is a potent nephrotoxin which nowadays contaminates human foods and water. On the other hands, it has been reported that rutin is a chemopreventive flavonoid which exerts some protective effects on the kidney. Therefore, in this work, the possible effect of rutin on HCBD-induced nephrotoxicity was investigated in female rats. The animals were divided into five groups. Groups 1 and 2 were treated with vehicle and HCBD (100 mg/kg, i.p.), respectively. Groups 3–5 were pretreated with rutin (100, 500 and 1000 mg/kg, i.p.) 1 h before HCBD injection. The level of serum urea and creatinine as well as urinary glucose and protein were measured. Total thiol content and lipid peroxidation level were also determined in the kidney homogenate. When compared to control group, a significant increase in the level of serum creatinine and urea (p < 0.001) as well as urine glucose and protein (p < 0.001) were observed after 24 h of HCBD administration. HCBD also caused a significant decrease in total thiol content (p < 0.001) and a significant increase in lipid peroxidation level (p < 0.001). Pretreatment with rutin could decrease serum creatinine (p < 0.001) and urea (p < 0.001) as well as urine protein (p < 0.001) concentrations when compared with HCBD treated rats. No significant modification on urine glucose was seen (p > 0.05). Rutin also reversed the HCBD-induced depletion in thiol content (p < 0.001) and elevation in lipid peroxidation (p < 0.001) in the kidney. The results of present study showed that rutin clearly attenuated HCBD-induced nephrotoxicity and has the potential to be considered as a nephroprotective agent.

9 August 2017 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
HGHamed Ghazavi
Hamed Ghazavi
SHSeyed Javad Hoseini
Seyed Javad Hoseini
AEAlireza Ebrahimzadeh-bideskan
Alireza Ebrahimzadeh-bideskan
BMBaratali Mashkani
Baratali Mashkani
SMSoghra Mehri
Soghra Mehri
MGMajid Ghayour-Mobarhan
Majid Ghayour-Mobarhan

23 April 2019 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
SFSahar Fanoudi
Sahar Fanoudi
MAMohaddeseh S. Alavi
Mohaddeseh S. Alavi
MHMahmoud Hosseini
Mahmoud Hosseini
HSHamid R. Sadeghnia
Hamid R. Sadeghnia